1. Home
  2. EBS
  3. EBS News

Latest Emergent Biosolutions Inc. (EBS) News on November 26, 2025

Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
EBS

GlobeNewswire

8 days ago

Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access

Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
EBS

GlobeNewswire

13 days ago

Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors

Black Diamond Therapeutics, Inc. (BDTX) Hits Fresh High: Is There Still Room to Run?
EBS

Zacks

14 days ago

Black Diamond Therapeutics, Inc. (BDTX) Hits Fresh High: Is There Still Room to Run?

Emergent BioSolutions' (NYSE:EBS) Solid Earnings Have Been Accounted For Conservatively
EBS

Simply Wall St.

19 days ago

Emergent BioSolutions' (NYSE:EBS) Solid Earnings Have Been Accounted For Conservatively

Emergent BioSolutions (EBS) Is Up 28.1% After Strong Q3 Results and Raised 2025 Guidance Has the Bull Case Changed?
EBS

Simply Wall St.

23 days ago

Emergent BioSolutions (EBS) Is Up 28.1% After Strong Q3 Results and Raised 2025 Guidance Has the Bull Case Changed?

Emergent Biosolutions Inc. (EBS) Soars to 52-Week High, Time to Cash Out?
EBS

Zacks

a month ago

Emergent Biosolutions Inc. (EBS) Soars to 52-Week High, Time to Cash Out?

Emergent BioSolutions (EBS) Earnings Transcript
EBS

Motley Fool

a month ago

Emergent BioSolutions (EBS) Earnings Transcript

Emergent BioSolutions Inc (EBS) Q3 2025 Earnings Call Highlights: Surpassing Revenue ...
EBS

GuruFocus.com

a month ago

Emergent BioSolutions Inc (EBS) Q3 2025 Earnings Call Highlights: Surpassing Revenue ...

Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates
EBS

Zacks

a month ago

Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates

EBS

Associated Press Finance

a month ago

Emergent Biosolutions: Q3 Earnings Snapshot

Emergent BioSolutions Reports Third Quarter 2025 Financial Results
EBS

GlobeNewswire

a month ago

Emergent BioSolutions Reports Third Quarter 2025 Financial Results

Investors in Emergent BioSolutions (NYSE:EBS) have unfortunately lost 90% over the last five years
EBS

Simply Wall St.

a month ago

Investors in Emergent BioSolutions (NYSE:EBS) have unfortunately lost 90% over the last five years

EBS

MT Newswires

a month ago

Emergent Biosolutions Insider Sold Shares Worth $306,080, According to a Recent SEC Filing

Bioscience Association Manitoba Welcomes New Board Members at Annual General Meeting
EBS

Business Wire

a month ago

Bioscience Association Manitoba Welcomes New Board Members at Annual General Meeting

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025
EBS

GlobeNewswire

2 months ago

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

EBS

MT Newswires

5 months ago

Emergent BioSolutions Awarded $62.4 Million Contract Modification for Botulism Antitoxin Supply

Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply
EBS

GlobeNewswire

5 months ago

Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply

EBS

MT Newswires

5 months ago

Emergent BioSolutions to Join Russell 3000 Index; Shares Up Pre-Bell

Emergent BioSolutions Announces Addition to Russell 3000® Index
EBS

GlobeNewswire

5 months ago

Emergent BioSolutions Announces Addition to Russell 3000® Index

Emergent BioSolutions Supports Victoria's Voice Foundation’s National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies
EBS

GlobeNewswire

6 months ago

Emergent BioSolutions Supports Victoria's Voice Foundation’s National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies

5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost
EBS

Zacks

6 months ago

5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost

Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions
EBS

Zacks

6 months ago

Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions

5 Broker-Loved Stocks to Watch Amid Signs of Easing Trade Woes
EBS

Zacks

6 months ago

5 Broker-Loved Stocks to Watch Amid Signs of Easing Trade Woes

EBS

Argus Research

6 months ago

Daily – Vickers Top Buyers & Sellers for 05/16/2025

EBS

MT Newswires

6 months ago

Emergent Biosolutions Insider Bought Shares Worth $349,800, According to a Recent SEC Filing

Emergent BioSolutions to Participate in Upcoming Investor Conferences
EBS

GlobeNewswire

6 months ago

Emergent BioSolutions to Participate in Upcoming Investor Conferences

EBS

Thomson Reuters StreetEvents

7 months ago

Q1 2025 Emergent BioSolutions Inc Earnings Call

Emergent BioSolutions Inc (EBS) Q1 2025 Earnings Call Highlights: Strong Net Income Growth Amid ...
EBS

GuruFocus.com

7 months ago

Emergent BioSolutions Inc (EBS) Q1 2025 Earnings Call Highlights: Strong Net Income Growth Amid ...

Emergent Biosolutions (EBS) Q1 Earnings Top Estimates
EBS

Zacks

7 months ago

Emergent Biosolutions (EBS) Q1 Earnings Top Estimates

EBS

Associated Press Finance

7 months ago

Emergent Biosolutions: Q1 Earnings Snapshot

Emergent BioSolutions Reports First Quarter 2025 Financial Results
EBS

GlobeNewswire

7 months ago

Emergent BioSolutions Reports First Quarter 2025 Financial Results

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health
EBS

GlobeNewswire

7 months ago

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025
EBS

GlobeNewswire

7 months ago

Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

Axsome (AXSM) Moves 4.2% Higher: Will This Strength Last?
EBS

Zacks

8 months ago

Axsome (AXSM) Moves 4.2% Higher: Will This Strength Last?

EBS

MT Newswires

8 months ago

Emergent BioSolutions Authorizes $50 Million Stock Buyback Program

Emergent BioSolutions Announces Stock Repurchase Program
EBS

GlobeNewswire

8 months ago

Emergent BioSolutions Announces Stock Repurchase Program

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08
EBS

GlobeNewswire

8 months ago

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
EBS

GlobeNewswire

8 months ago

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

EBS

MT Newswires

8 months ago

Emergent BioSolutions Completes Sale of Baltimore-Bayview Facility to Syngene International

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
EBS

GlobeNewswire

8 months ago

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products
EBS

GlobeNewswire

8 months ago

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

High Growth Tech Stocks In The US Market March 2025
EBS

Simply Wall St.

8 months ago

High Growth Tech Stocks In The US Market March 2025

Emergent signs financial investment agreement with Swiss Rockets
EBS

Pharmaceutical Technology

8 months ago

Emergent signs financial investment agreement with Swiss Rockets

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs
EBS

GlobeNewswire

8 months ago

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

EBS

MT Newswires

8 months ago

Emergent BioSolutions to Invest in Swiss Rockets, Rocketvax

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates
EBS

GlobeNewswire

8 months ago

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

EBS

MT Newswires

9 months ago

Emergent to Sell Baltimore-Bayview Facility for $36.5 Million

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
EBS

GlobeNewswire

9 months ago

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Emergent BioSolutions Inc. (NYSE:EBS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
EBS

Simply Wall St.

9 months ago

Emergent BioSolutions Inc. (NYSE:EBS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

EBS

Thomson Reuters StreetEvents

9 months ago

Q4 2024 Emergent BioSolutions Inc Earnings Call

Emergent BioSolutions (EBS) Q4 2024 Earnings Call Transcript
EBS

Motley Fool

9 months ago

Emergent BioSolutions (EBS) Q4 2024 Earnings Call Transcript

Emergent BioSolutions Inc (EBS) Q4 2024 Earnings Call Highlights: Strategic Advancements Amid ...
EBS

GuruFocus.com

9 months ago

Emergent BioSolutions Inc (EBS) Q4 2024 Earnings Call Highlights: Strategic Advancements Amid ...

Emergent Biosolutions (EBS) Q4 Earnings Top Estimates
EBS

Zacks

9 months ago

Emergent Biosolutions (EBS) Q4 Earnings Top Estimates

EBS

MT Newswires

9 months ago

Emergent BioSolutions Swings to Q4 Earnings, Revenue Declines -- Shares Fall After Hours

EBS

Associated Press Finance

9 months ago

Emergent Biosolutions: Q4 Earnings Snapshot

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results
EBS

GlobeNewswire

9 months ago

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

Emergent BioSolutions Inc. (NYSE:EBS) is favoured by institutional owners who hold 64% of the company
EBS

Simply Wall St.

9 months ago

Emergent BioSolutions Inc. (NYSE:EBS) is favoured by institutional owners who hold 64% of the company

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
EBS

GlobeNewswire

9 months ago

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans
EBS

GlobeNewswire

10 months ago

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans

Emergent seeking to reverse fortunes and become a major overdose treatment player
EBS

Pharmaceutical Technology

10 months ago

Emergent seeking to reverse fortunes and become a major overdose treatment player

Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)
EBS

GlobeNewswire

10 months ago

Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

EBS

MT Newswires

10 months ago

Emergent BioSolutions Obtains Commercial Rights to Kloxxado Nasal Spray

Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
EBS

GlobeNewswire

10 months ago

Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals

EBS

MT Newswires

10 months ago

Emergent Gets Contract Option With BARDA for Ebola Treatment

Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola
EBS

GlobeNewswire

10 months ago

Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola

Those who invested in Emergent BioSolutions (NYSE:EBS) a year ago are up 365%
EBS

Simply Wall St.

a year ago

Those who invested in Emergent BioSolutions (NYSE:EBS) a year ago are up 365%

EBS

MT Newswires

a year ago

Emergent BioSolutions Receives $20 Million Contract to Supply Anthrax Vaccine to US Military

Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
EBS

GlobeNewswire

a year ago

Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)
EBS

GlobeNewswire

a year ago

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)

Why Emergent BioSolutions Stock Blasted Higher Today
EBS

Motley Fool

a year ago

Why Emergent BioSolutions Stock Blasted Higher Today

EBS

MT Newswires

a year ago

Sector Update: Health Care Stocks Lower Monday Afternoon

EBS

MT Newswires

a year ago

Emergent BioSolutions Shares Rise After HC Wainwright Begins Coverage With Buy Rating

Emergent Stock Skyrockets 251% YTD: How to Play the Stock?
EBS

Zacks

a year ago

Emergent Stock Skyrockets 251% YTD: How to Play the Stock?

EBS

MT Newswires

a year ago

Emergent BioSolutions Wins $50 Million Contract Option for Cyfendus; Shares Rise

Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
EBS

GlobeNewswire

a year ago

Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

Why Emergent BioSciences Stock Plummeted Today
EBS

Motley Fool

a year ago

Why Emergent BioSciences Stock Plummeted Today

EBS

MT Newswires

a year ago

Emergent Biosolutions Insider Sold Shares Worth $272,750, According to a Recent SEC Filing

Emergent BioSolutions Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
EBS

Simply Wall St.

a year ago

Emergent BioSolutions Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Emergent BioSolutions Inc (EBS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
EBS

GuruFocus.com

a year ago

Emergent BioSolutions Inc (EBS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024
EBS

Benzinga

a year ago

Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024

EBS

MT Newswires

a year ago

Top Premarket Gainers

New Strong Buy Stocks for November 7th
EBS

Zacks

a year ago

New Strong Buy Stocks for November 7th

Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript
EBS

Motley Fool

a year ago

Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript

Emergent Biosolutions (EBS) Q3 Earnings Beat Estimates
EBS

Zacks

a year ago

Emergent Biosolutions (EBS) Q3 Earnings Beat Estimates

EBS

Associated Press Finance

a year ago

Emergent Biosolutions: Q3 Earnings Snapshot

Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa
EBS

GlobeNewswire

a year ago

Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa

Emergent BioSolutions Reports Third Quarter 2024 Financial Results
EBS

GlobeNewswire

a year ago

Emergent BioSolutions Reports Third Quarter 2024 Financial Results

Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development
EBS

GlobeNewswire

a year ago

Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development

Zacks.com featured highlights include American Airlines, Air Canada, EmergentBioSolutions, Berry and Cracker Barrel Old Country Store
EBS

Zacks

a year ago

Zacks.com featured highlights include American Airlines, Air Canada, EmergentBioSolutions, Berry and Cracker Barrel Old Country Store

5 Broker Liked Stocks to Keep an Eye on After Recent Analyst Upgrades
EBS

Zacks

a year ago

5 Broker Liked Stocks to Keep an Eye on After Recent Analyst Upgrades

Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024
EBS

GlobeNewswire

a year ago

Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024

Zacks.com featured highlights include Grupo Supervielle, Emergent BioSolutions and Innodata
EBS

Zacks

a year ago

Zacks.com featured highlights include Grupo Supervielle, Emergent BioSolutions and Innodata

3 Stocks Poised for Better Returns With New Analyst Coverage
EBS

Zacks

a year ago

3 Stocks Poised for Better Returns With New Analyst Coverage

Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024
EBS

Insider Monkey

a year ago

Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024

Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and ...
EBS

GuruFocus.com

a year ago

Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and ...

Emergent to donate 20,000 Narcan doses to fight opioid overdoses, CEO says
EBS

Pharmaceutical Technology

a year ago

Emergent to donate 20,000 Narcan doses to fight opioid overdoses, CEO says

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic
EBS

GlobeNewswire

a year ago

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic

EBS

MT Newswires

a year ago

Emergent Enters New $100 Million Revolving Credit Agreement

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility
EBS

GlobeNewswire

a year ago

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility

High Growth Tech Stocks To Watch This October 2024
EBS

Simply Wall St.

a year ago

High Growth Tech Stocks To Watch This October 2024

Share on Social Networks: